Viewing Study NCT01253551


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-05-30 @ 9:15 AM
Study NCT ID: NCT01253551
Status: COMPLETED
Last Update Posted: 2012-10-16
First Post: 2010-12-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Sponsor: Tibotec BVBA
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C View
Keywords:

Keywords

Keyword Brief Keyword Text View
None VX-950HEP1001 View
None hepatitis View
None telaprevir View
None raltegravir View
None crossover View
None healthy volunteers View
None VX-950. View